Literature DB >> 35460459

One-pot multicomponent synthesis of benzophenazine tethered tetrahydropyridopyrimidine derivatives.

Tasneem Parvin1.   

Abstract

A simple, facile, and efficient green methodology has been developed for the synthesis of benzophenazine tethered tetrahydropyridopyrimidine derivatives by the one-pot four-component reaction of cinnamaldehyde/crotonaldehyde, 2-hydroxy-1,4-naphthoquinone, 1,3-dimethyl-6-amino uracil, and o-phenylenediamine in ethanol medium under reflux conditions using p-TSA as a catalyst. In this environmentally benign methodology, three C-N and two C-C bonds are formed in one pot. The hybrid products have three bioactive moieties such as benzophenazine, tetrahydropyridine, and pyrimidine. Operational simplicity, metal-free conditions, wide substrate scope, readily available starting materials, moderate to good yields of the desired products, presence of pharmaceutically active moieties, and easy purification process are the notable features of this methodology.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Benzophenazine; Multicomponent reaction; One pot; Pyrimidine; Tetrahydropyridine

Year:  2022        PMID: 35460459     DOI: 10.1007/s11030-022-10426-4

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  23 in total

1.  The pterocellins, novel bioactive alkaloids from the marine bryozoan Pterocella vesiculosa.

Authors:  Biao Yao; Michèle R Prinsep; Brian K Nicholson; Dennis P Gordon
Journal:  J Nat Prod       Date:  2003-08       Impact factor: 4.050

Review 2.  Phenazine natural products: biosynthesis, synthetic analogues, and biological activity.

Authors:  Jane Buus Laursen; John Nielsen
Journal:  Chem Rev       Date:  2004-03       Impact factor: 60.622

3.  Structure-activity relationships for pyrido-, imidazo-, pyrazolo-, pyrazino-, and pyrrolophenazinecarboxamides as topoisomerase-targeted anticancer agents.

Authors:  Swarna A Gamage; Julie A Spicer; Gordon W Rewcastle; John Milton; Sukhjit Sohal; Wendy Dangerfield; Prakash Mistry; Nigel Vicker; Peter A Charlton; William A Denny
Journal:  J Med Chem       Date:  2002-01-31       Impact factor: 7.446

4.  Rational Molecular Design of Dibenzo[a,c]phenazine-Based Thermally Activated Delayed Fluorescence Emitters for Orange-Red OLEDs with EQE up to 22.0.

Authors:  Feng-Ming Xie; Hao-Ze Li; Guo-Liang Dai; Yan-Qing Li; Tao Cheng; Miao Xie; Jian-Xin Tang; Xin Zhao
Journal:  ACS Appl Mater Interfaces       Date:  2019-07-12       Impact factor: 9.229

5.  A new class of phenazines with activity against a chloroquine resistant Plasmodium falciparum strain and antimicrobial activity.

Authors:  Hidayat Hussain; Sabine Specht; Salem R Sarite; Michael Saeftel; Achim Hoerauf; Barbara Schulz; Karsten Krohn
Journal:  J Med Chem       Date:  2011-06-08       Impact factor: 7.446

6.  Inhibition of the human platelet cyclooxygenase response by the naturally occurring phenazine derivative, 1-hydroxyphenazine.

Authors:  M Muller; T C Sorrell
Journal:  Prostaglandins       Date:  1995 Nov-Dec

Review 7.  Lamellarins, from A to Z: a family of anticancer marine pyrrole alkaloids.

Authors:  Christian Bailly
Journal:  Curr Med Chem Anticancer Agents       Date:  2004-07

8.  Synthesis, antitumor activity, and structure-activity relationship of some benzo[a]pyrano[2,3-c]phenazine derivatives.

Authors:  Jing Gao; Ming Chen; Xue Tong; He Zhu; Hongbin Yan; Daichun Liu; Wanjing Li; Shengyu Qi; Dake Xiao; Yongzhi Wang; Yuanyuan Lu; Feng Jiang
Journal:  Comb Chem High Throughput Screen       Date:  2015       Impact factor: 1.339

Review 9.  Phenazines and cancer.

Authors:  A Cimmino; A Evidente; V Mathieu; A Andolfi; F Lefranc; A Kornienko; R Kiss
Journal:  Nat Prod Rep       Date:  2012-02-15       Impact factor: 13.423

10.  Antimalarial activity of phenazines from lapachol, beta-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.

Authors:  Valter F de Andrade-Neto; Marília O F Goulart; Jorge F da Silva Filho; Matuzalém J da Silva; Maria do Carmo F R Pinto; Antônio V Pinto; Mariano G Zalis; Luzia H Carvalho; Antoniana U Krettli
Journal:  Bioorg Med Chem Lett       Date:  2004-03-08       Impact factor: 2.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.